Alveolar Proteinosis

Summary about Disease


Pulmonary alveolar proteinosis (PAP) is a rare lung disorder characterized by the abnormal accumulation of surfactant-derived lipoprotein in the alveoli (air sacs) of the lungs. This buildup impairs gas exchange, leading to breathing difficulties. PAP can be congenital (present at birth), secondary to other conditions, or autoimmune (most common). The autoimmune form is caused by antibodies that neutralize granulocyte-macrophage colony-stimulating factor (GM-CSF), a protein essential for surfactant clearance by alveolar macrophages.

Symptoms


Symptoms vary in severity but commonly include:

Progressive shortness of breath (dyspnea), especially with exertion

Cough (may be dry or produce thick, chunky sputum)

Fatigue

Weight loss

Low-grade fever

Cyanosis (bluish discoloration of the skin due to low oxygen levels) in severe cases

Crackles (abnormal lung sounds heard with a stethoscope)

Causes


Autoimmune PAP: Most common type, caused by antibodies against GM-CSF.

Secondary PAP: Can be associated with exposure to inhaled dusts (silica, aluminum), certain infections, hematologic malignancies (leukemia), and immune deficiencies.

Congenital PAP: Rare genetic mutations affecting surfactant production or GM-CSF signaling cause this form.

Medicine Used


GM-CSF therapy: Recombinant human GM-CSF (sargramostim or molgramostim) can be administered by subcutaneous injection or inhalation to stimulate surfactant clearance. This is used more commonly in Europe and Japan.

Antibiotics: To treat secondary infections.

Corticosteroids: Occasionally used to manage inflammation but are generally not the primary treatment.

Whole lung lavage (WLL): A procedure where the lungs are sequentially washed out with saline to remove the accumulated proteinaceous material. This is a common first-line treatment.

Is Communicable


No, pulmonary alveolar proteinosis is not communicable or contagious. It is not caused by an infectious agent.

Precautions


Since PAP isn't communicable, standard infection control precautions don't apply. However, patients with PAP should:

Avoid exposure to inhaled irritants and pollutants (smoke, dust, fumes).

Get vaccinated against influenza and pneumococcal pneumonia.

Follow their doctor's recommendations for pulmonary hygiene and treatment adherence.

Report any signs of respiratory infection promptly.

How long does an outbreak last?


PAP doesn't present as an "outbreak" since it is not infectious. The disease is chronic and can have variable courses. The duration of symptoms and the need for treatment can vary significantly from person to person. Some individuals may experience periods of stability, while others require repeated whole-lung lavages or ongoing medical management.

How is it diagnosed?


Diagnosis typically involves:

Chest X-ray or CT scan: Shows characteristic "ground-glass" opacities in the lungs.

Bronchoscopy with bronchoalveolar lavage (BAL): BAL fluid appears milky or opaque and contains characteristic proteinaceous material.

Lung biopsy: May be performed in some cases to confirm the diagnosis.

GM-CSF antibody testing: Blood test to detect antibodies against GM-CSF, which is diagnostic of autoimmune PAP.

Pulmonary function tests: To assess lung function and severity of impairment.

Timeline of Symptoms


The timeline of symptoms can vary. It is usually progressive:

Early: Mild shortness of breath, often only with exertion. Dry cough may be present.

Intermediate: Shortness of breath worsens, becoming noticeable with less exertion. Fatigue develops. Cough may become productive with thick sputum.

Late: Significant shortness of breath even at rest. Cyanosis, weight loss, and respiratory failure can occur. Secondary infections are more common.

Important Considerations


PAP is a rare disease, so diagnosis can be delayed.

Treatment is often individualized based on the severity of symptoms and the underlying cause.

Long-term follow-up is essential to monitor disease progression and response to therapy.

Research is ongoing to develop new and more effective treatments for PAP.

Patient support groups can provide valuable information and emotional support.